Boxer Capital’s Akero Therapeutics AKRO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-1,676,733
| Closed | -$48.1M | – | 1 |
|
|
2024
Q3 | $48.1M | Hold |
1,676,733
| – | – | 2.36% | 14 |
|
|
2024
Q2 | $39.3M | Hold |
1,676,733
| – | – | 2.07% | 15 |
|
|
2024
Q1 | $42.4M | Hold |
1,676,733
| – | – | 2.09% | 15 |
|
|
2023
Q4 | $39.2M | Hold |
1,676,733
| – | – | 1.95% | 18 |
|
|
2023
Q3 | $84.8M | Hold |
1,676,733
| – | – | 4.51% | 5 |
|
|
2023
Q2 | $78.3M | Buy |
1,676,733
+845,238
| +102% | +$39.5M | 3.63% | 7 |
|
|
2023
Q1 | $31.8M | Hold |
831,495
| – | – | 1.56% | 18 |
|
|
2022
Q4 | $45.6M | Hold |
831,495
| – | – | 2.4% | 12 |
|
|
2022
Q3 | $28.3M | Hold |
831,495
| – | – | 1.59% | 23 |
|
|
2022
Q2 | $7.86M | Hold |
831,495
| – | – | 0.5% | 44 |
|
|
2022
Q1 | $11.8M | Hold |
831,495
| – | – | 0.61% | 40 |
|
|
2021
Q4 | $17.6M | Hold |
831,495
| – | – | 0.68% | 33 |
|
|
2021
Q3 | $18.6M | Hold |
831,495
| – | – | 0.65% | 45 |
|
|
2021
Q2 | $20.6M | Hold |
831,495
| – | – | 0.73% | 42 |
|
|
2021
Q1 | $24.1M | Hold |
831,495
| – | – | 0.82% | 37 |
|
|
2020
Q4 | $21.5M | Hold |
831,495
| – | – | 0.69% | 41 |
|
|
2020
Q3 | $25.6M | Buy |
831,495
+415,000
| +100% | +$12.8M | 0.88% | 32 |
|
|
2020
Q2 | $10.4M | Hold |
416,495
| – | – | 0.46% | 46 |
|
|
2020
Q1 | $8.83M | Sell |
416,495
-66,000
| -14% | -$1.4M | 0.6% | 38 |
|
|
2019
Q4 | $10.7M | Hold |
482,495
| – | – | 0.61% | 38 |
|
|
2019
Q3 | $11M | Buy |
482,495
+85,800
| +22% | +$1.95M | 0.8% | 30 |
|
|
2019
Q2 | $7.6M | Buy |
+396,695
| New | +$7.6M | 0.65% | 27 |
|